Tone mix
Week by week 52 weeks
Share of Viatris Inc. Common Stock's 158 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Nov 24, 2025 · tone +100Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know+85
- Week of Jul 20, 2026 · tone -64FDA issues untitled letters to Sanofi and Viatris for false advertising-84
- Week of Sep 14, 2026 · tone +100Viatris' Wakix receives Japanese approval to treat OSAS and narcolepsy+75
- Week of Sep 29, 2025 · tone 0Viatris: The Importance of a Global, Resilient Supply Chain to Access-75
- Week of Sep 1, 2025 · tone +100Viatris, Inc. (VTRS) Achieves Key Clinical Milestones in Ophthalmology, Pain, Women's Health+74
- Week of Sep 21, 2026 · tone +100Viatris (VTRS) Wins Japan WAKIX Approval. Can it Build a Meaningful Specialty Business?+70
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Viatris Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 1 | +87 |
| Last 30 sessions | 18 | +55 |
| Last 90 sessions | 49 | +35 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 21, 2026
1 headline, average tone +87: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletViatris drives regional dialogue to advance cardiovascular care across Southeast AsiaPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Viatris drives regional dialogue to advance cardiovascular care across Southeast Asia | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.insidermonkey.com · 1 outletViatris' Dividend Has Room to Grow, but Will Management Deliver?Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Viatris' Dividend Has Room to Grow, but Will Management Deliver? | www.insidermonkey.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
3 headlines, average tone +66: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.rttnews.com · 2 outletsFDA Approves Viatris' RYZUMVI For Presbyopia TreatmentPositive
- www.pharmaceutical-business-review.com · 1 outletFDA approves Viatris' Ryzumvi for adult presbyopiaPositive
- healthcare-digital.com · 1 outletStryker, Viatris, Flo, Teva, J&J: This Week in HealthcareNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FDA Approves Viatris' RYZUMVI For Presbyopia Treatment | www.rttnews.com | 2 | Positive |
| FDA approves Viatris' Ryzumvi for adult presbyopia | www.pharmaceutical-business-review.com | 1 | Positive |
| Stryker, Viatris, Flo, Teva, J&J: This Week in Healthcare | healthcare-digital.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
2 headlines, average tone +31: 1 positive, 1 neutral and 0 negative. Showing all 2.
- healthcare-digital.com · 1 outletViatris to Acquire Pacira in US$1.65bn Pain Management DealPositive
- www.bioxconomy.com · 1 outletViatris to absorb Pacira in $1.65bn transactionNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Viatris to Acquire Pacira in US$1.65bn Pain Management Deal | healthcare-digital.com | 1 | Positive |
| Viatris to absorb Pacira in $1.65bn transaction | www.bioxconomy.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 9, 2026
7 headlines, average tone +40: 3 positive, 4 neutral and 0 negative. Showing all 7.
- www.rttnews.com · 2 outletsViatris Agrees To Acquire Pacira BioSciences In $1.65 Bln Cash DealPositive
- www.biopharmadive.com · 1 outletViatris boosts pain drug portfolio with $1.7B buyout of PaciraPositive
- www.insidermonkey.com · 1 outletCould an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff?Positive
- www.law360.com · 1 outletViatris To Buy Pacira BioSciences For $1.65BNeutral
- seekingalpha.com · 1 outletPacira BioSciences jumps 44% on Viatris acquisition deal (PCRX:NASDAQ)Neutral
- www.miragenews.com · 1 outletPacira BioSciences to Be Acquired by Viatris for $1.65BNeutral
- seekingalpha.com · 1 outlet4 stocks to watch on Thursday: AVGO, PLTR, AMZN, and VTRS (SP500:)Neutral
Show the table · 7 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Viatris Agrees To Acquire Pacira BioSciences In $1.65 Bln Cash Deal | www.rttnews.com | 2 | Positive |
| Viatris boosts pain drug portfolio with $1.7B buyout of Pacira | www.biopharmadive.com | 1 | Positive |
| Could an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff? | www.insidermonkey.com | 1 | Positive |
| Viatris To Buy Pacira BioSciences For $1.65B | www.law360.com | 1 | Neutral |
| Pacira BioSciences jumps 44% on Viatris acquisition deal (PCRX:NASDAQ) | seekingalpha.com | 1 | Neutral |
| Pacira BioSciences to Be Acquired by Viatris for $1.65B | www.miragenews.com | 1 | Neutral |
| 4 stocks to watch on Thursday: AVGO, PLTR, AMZN, and VTRS (SP500:) | seekingalpha.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Viatris Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.